Mediwound

Mediwound Intangible Assets

The Intangible Assets of Mediwound (MDWD) as of Nov 22, 2026 is 99,000.00 USD. In the previous year, Intangible Assets was 165,000.00 USD — a change of -40.00% (lower).

Intangible Assets

99,000.00USD

YoY

-40.00%

Last updated:

Intangible Assets of Mediwound is 2024 99,000.00 USD. Intangible Assets of Mediwound was 2023 165,000.00 USD. It decreases by -40.00% lower compared to the previous year.

The Mediwound Intangible Assets history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Intangible Assets
Date
Intangible Assets
Jan 1, 2017
640,000.00 USD
Jan 1, 2018
500,000.00 USD
Jan 1, 2019
430,000.00 USD
Jan 1, 2020
360,000.00 USD
Jan 1, 2021
300,000.00 USD
Jan 1, 2022
230,000.00 USD
Jan 1, 2023
165,000.00 USD
Jan 1, 2024
99,000.00 USD
The Mediwound Intangible Assets history
YEARIntangible AssetsYoY
99,000.00USD-40.00%
165,000.00USD-28.26%
230,000.00USD-23.33%
300,000.00USD-16.67%
360,000.00USD-16.28%
430,000.00USD-14.00%
500,000.00USD-21.88%
640,000.00USD-16.88%
770,000.00USD-14.44%
900,000.00USD-5.26%
950,000.00USD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Mediwound Stock analysis

What does Mediwound do? Mediwound Ltd is an Israeli company specializing in the development and marketing of therapies for chronic and acute wounds. The company was founded in 2000 and is headquartered in Yavne, Israel. Its history began with the idea of developing an innovative treatment method for burns. The company collaborated closely with the Israeli Ministry of Defense to find a better method for wound treatment. The result was the product NexoBrid, an enzymatic debridement treatment that aims to remove dead tissue from burn wounds to enable faster healing. Mediwound's business model is to develop and market innovative drugs and therapy solutions for wounds. The company operates in several areas, including burn wounds, chronic wounds, and trauma wounds. In the burn wounds sector, Mediwound offers the product NexoBrid, which enzymatically removes dead tissue from burns and eliminates neurotoxic substances that can damage wound healing if left in the tissue for too long. NexoBrid is already approved in several countries, including the USA and European countries. In the chronic wounds sector, Mediwound offers the product EscharEx, which is used to treat chronic wounds such as pressure ulcers, diabetic foot ulcers, and venous leg ulcers. EscharEx also uses an enzymatic approach and aims to remove dead tissue to enable the body's natural healing process. There are plans to launch EscharEx in Europe in the second half of 2021. Mediwound also operates in the trauma wounds sector and received the product MWPC003 in Europe in 2020. It is a novel enzymatic debriding product that can be used in the integrated therapy of complex trauma wounds with additional topical treatment options. Through the development of innovative therapies and drugs, Mediwound has established itself as a reliable partner in wound treatment. The company continues to focus on innovation and plans to expand its product range in the future. Overall, Mediwound Ltd is a groundbreaking company in the field of wound care. The company's products and solutions contribute to faster and more effective wound healing, improving the lives of patients worldwide. Mediwound is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Mediwound stock

Intangible Assets of Mediwound is 99,000.00 USD in 2024.

Intangible Assets of Mediwound changed from 165,000.00 USD to 99,000.00 USD, representing a -40.00% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Intangible Assets Mediwound since 2006 – with annual values, charts, and detailed analysis.

Intangible assets are non-physical assets such as patents, trademarks, copyrights, and software. They can be significant value drivers for technology and pharmaceutical companies.

Intangible Assets's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Intangible Assets's Mediwound historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Mediwound

All Key Metrics — Mediwound